FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy-Reference-Cited by-同舟云学术

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Published:2018-01-25 Issue:5 Volume:7 Page:e1423183
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Pyrzynska Beata¹^ORCID,Dwojak Michal¹²,Zerrouqi Abdessamad¹,Morlino Giulia³,Zapala Piotr¹,Miazek Nina¹,Zagozdzon Agnieszka¹,Bojarczuk Kamil¹,Bobrowicz Malgorzata¹,Siernicka Marta¹²,Machnicki Marcin M.¹²,Gobessi Stefania⁴,Barankiewicz Joanna⁵⁶,Lech-Maranda Ewa⁵⁶,Efremov Dimitar G.⁴,Juszczynski Przemyslaw⁵,Calado Dinis³⁷,Golab Jakub¹⁸,Winiarska Magdalena¹

Affiliation:

1. Department of Immunology, Medical University of Warsaw, Warsaw, Poland

2. Postgraduate School of Molecular Medicine, Warsaw, Poland

3. The Francis Crick Institute, London, United Kingdom

4. Department of Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy

5. Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland

6. Department of Hematology and Transfusion Medicine, Center of Postgraduate Medical Education, Warsaw, Poland

7. Peter Gorer Department of Immunobiology, Kings College London, United Kingdom

8. Centre for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland

Funder

Ministry of Science and Higher Education

National Science Center

European Commission

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1423183

Reference46 articles.

1. Germinal centres and B cell lymphomagenesis

2. The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program

3. PI3 Kinase and FOXO1 Transcription Factor Activity Differentially Control B Cells in the Germinal Center Light and Dark Zones

4. FOXO1 Transcription Factor: A Critical Effector of the PI3K-AKT Axis in B-Cell Development

5. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to anti-CD20 antibodies in lymphoid malignancies;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. Anti-CD20 antibody treatment for diffuse large B cell lymphoma: Genetic alterations and signaling pathways;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

3. Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies;Blood;2023-11-16

4. Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL);Molecular Case Studies;2023-09-20

5. FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors;Cancer Immunology Research;2023-08-30